Mobia Medical, Inc. — Form 8-K
Filed July 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-07-15 reports Item 5.02 disclosure regarding departure of directors or officers and compensatory arrangements. Specific names, dollar amounts, share counts, and dates of departures or new arrangements are not provided in the header text available.
Why this rating
Item 5.02 filing is routine personnel disclosure. Without specific departure details, compensation amounts, or equity impact quantified in accessible text, material assessment is limited. Routine officer transition at $73.6M-asset company.
Extracted items
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.